In 2016, a mother filed a lawsuit relating to the death of her son Christian against a diagnostic company. When Christian began experiencing a series of unrelenting seizures, the company performed a massive battery of tests, including the sequencing of a gene called SCN1A. At the time, the company reported that he had a variant of unknown significance (VUS) there. What the company did not realize was that there was a peer-reviewed study that had identified the same SCN1A mutation in an Australian family one year earlier. Christian received inappropriate treatment and died from a seizure months later.
{iframe}https://go.qiagen.com/HGMD_and_ClinVar_WhitePaper?utm_source=%20DGCDx_WEB_BIOX_0418_HGMD_EM_Labroots_NA{/iframe}